INFINITY PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Infinity Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q2 2023.
  • Infinity Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2023 was 90.8M shares, a 1.66% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 90.8M +1.48M +1.66% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 89.4M +267K +0.3% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 89.4M +256K +0.29% Dec 31, 2022 10-Q 2023-08-10
Q3 2022 89.3M +414K +0.47% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 89.3M +558K +0.63% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 89.2M +508K +0.57% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 89.2M +24.8M +38.6% Dec 31, 2021 10-K 2023-03-28
Q3 2021 88.9M +25.8M +40.8% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 88.7M +31.2M +54.3% Jun 30, 2021 10-Q 2021-07-27
Q1 2021 88.6M +31.2M +54.3% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 64.3M +7.24M +12.7% Dec 31, 2020 10-K 2022-03-29
Q3 2020 63.1M +6.11M +10.7% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 57.5M +467K +0.82% Jun 30, 2020 10-Q 2020-07-30
Q1 2020 57.4M +508K +0.89% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 57.1M +170K +0.3% Dec 31, 2019 10-K 2021-03-16
Q3 2019 57M +173K +0.31% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 57M +193K +0.34% Jun 30, 2019 10-Q 2019-07-30
Q1 2019 56.9M +3.23M +6.01% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 56.9M +6.15M +12.1% Dec 31, 2018 10-K 2020-03-03
Q3 2018 56.9M +6.17M +12.2% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 56.8M +6.35M +12.6% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 53.7M +3.27M +6.49% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 50.8M +386K +0.77% Dec 31, 2017 10-K 2019-03-14
Q3 2017 50.7M +1.1M +2.22% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 50.5M +974K +1.97% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 50.4M +1.08M +2.18% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 50.4M +1.07M +2.17% Dec 31, 2016 10-K 2018-03-15
Q3 2016 49.6M +390K +0.79% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 49.5M +344K +0.7% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 49.3M +321K +0.65% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 49.3M +426K +0.87% Dec 31, 2015 10-K 2017-03-14
Q3 2015 49.2M +473K +0.97% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 49.2M +579K +1.19% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 49M +510K +1.05% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 48.9M +651K +1.35% Dec 31, 2014 10-K 2016-02-23
Q3 2014 48.7M +639K +1.33% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 48.6M +603K +1.26% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 48.5M +689K +1.44% Mar 31, 2014 10-Q 2014-05-06
Q4 2013 48.2M +729K +1.53% Dec 31, 2013 10-K 2015-02-24
Q3 2013 48.1M +8.61M +21.8% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 48M +20.7M +76% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 47.8M +20.9M +77.9% Mar 31, 2013 10-Q 2013-05-07
Q4 2012 47.5M +20.8M +77.8% Dec 31, 2012 10-K 2014-02-25
Q3 2012 39.5M +12.8M +48% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 27.3M +667K +2.51% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 26.9M Mar 31, 2012 10-Q 2012-05-08
Q4 2011 26.7M +203K +0.76% Dec 31, 2011 10-K 2013-03-05
Q3 2011 26.7M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 26.6M Jun 30, 2011 10-Q 2011-08-09
Q4 2010 26.5M Dec 31, 2010 10-K 2012-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.